Influence of Gibberellic acid and Methionine on growth, flowering quality, leaf anatomical structure and genetic diversity of Chrysanthemum morifolium Ramat plant

Ornamental plants are grown all over the world. In most countries, Chrysanthemum is considered one of the most popular cuts and potted flowers. Plants were sprayed with gibberellic acid (GA3) at concentrations (100, 200, and 300 ppm) and methionine (ME) at levels (200, 400, and 600 ppm), as bio-growth stimulants in the pre-blooming stage. The morphological and flowering parameters significantly increased by increasing the concentration of GA3. The highest values of K%, P%, total carbohydrates content, total phenols, total chlorophylls, and carotenoids in the leaf were obtained from gibberellic acid treatment at the rate of 300 ppm, while methionine at 600 ppm gave the highest value of protein in flowers. Also, various levels of gibberellic acid application significantly showed variation for days to initiation of Chrysanthemum flowers. The results of leaf anatomy showed an increase in most characteristics such as (thickness of the main vein, lamina, and spongy tissue) under study when spraying with gibberellic acid, especially at the concentration of 300 and methionine 600 ppm; respectively compared with control. Furthermore, inter-simple sequence repeat (ISSR) analysis has provided a powerful molecular marker for identifying variation with control and the best treatments. Therefore, the utilization of 300 ppm GA3 a plant growth regulator and 600 ppm ME an amino acid, these treatments are recommended to enhance Chrysanthemum parameters which lead to increasing its economic value as cut flowers and flowering potted plants as well as pharmaceuticals industries and multi-chemical uses.Keywords: Cut flowers; bio-growth stimulants; ISSR; leaf anatomy, growth regulators

Influence of Gibberellic acid and Methionine on growth, flowering quality, leaf anatomical structure and genetic diversity of Chrysanthemum morifolium Ramat plant

Ornamental plants are grown all over the world. In most countries, Chrysanthemum is considered one of the most popular cuts and potted flowers. Plants were sprayed with gibberellic acid (GA3) at concentrations (100, 200, and 300 ppm) and methionine (ME) at levels (200, 400, and 600 ppm), as bio-growth stimulants in the pre-blooming stage. The morphological and flowering parameters significantly increased by increasing the concentration of GA3. The highest values of K%, P%, total carbohydrates content, total phenols, total chlorophylls, and carotenoids in the leaf were obtained from gibberellic acid treatment at the rate of 300 ppm, while methionine at 600 ppm gave the highest value of protein in flowers. Also, various levels of gibberellic acid application significantly showed variation for days to initiation of Chrysanthemum flowers. The results of leaf anatomy showed an increase in most characteristics such as (thickness of the main vein, lamina, and spongy tissue) under study when spraying with gibberellic acid, especially at the concentration of 300 and methionine 600 ppm; respectively compared with control. Furthermore, inter-simple sequence repeat (ISSR) analysis has provided a powerful molecular marker for identifying variation with control and the best treatments. Therefore, the utilization of 300 ppm GA3 a plant growth regulator and 600 ppm ME an amino acid, these treatments are recommended to enhance Chrysanthemum parameters which lead to increasing its economic value as cut flowers and flowering potted plants as well as pharmaceuticals industries and multi-chemical uses.Keywords: Cut flowers; bio-growth stimulants; ISSR; leaf anatomy, growth regulators

High risk Langerhans cell histiocytosis in children: the role of salvage in improving the outcome. A single center experience

Abstract Background In pediatric multi-system high risk organs (RO +) Langerhans cell histiocytosis (LCH), failing 1st line treatment has the highest mortality. We aim to present the outcome of failure of 1st line whether due to disease progression (DP) at end of induction or reactivation (REA) after initial better status response. Patients and methods Sixty-seven RO + LCH patients with hemopoietic, hepatic or splenic involvement, treated between 2007 and 2019 were retrospectively analyzed. The median follow-up (IQR) is 6 years (4–8.8 y).They were subjected to 2 eras of treatment; one with salvage by 2-Cda based regimen (2-CdABR) and another without. Results Of 67 patients, M/F 40/27, median age 1.74 y (0.2–10 y), 42 failed 1st line (62.7%). Of them DP n = 22 (52%) and REA n = 20 (48%). Of those with DP, 9/22 patients received 2-CdABR, where 5 survived in better status. While the remaining 13 did not receive 2-CdABR and all of them died. Otherwise, of those with REA, 12/20 reactivated on RO + mode. Of them, 8/12 received 2-CdABR, where only one survived in better status and the remaining 4 received vinblastine-based regimen,where 2 died and 2 were rescued. RO + 5-year overall survival (OS) was 65% (CI 95% 54 -78) while the event free survival (EFS) 36% (26.3—50.1). The OS of DP 27% (14–54) versus REA 67% (49–93) p 0.004. OS of DP with 2-CdABR 56% (31–97.7) versus 8% without (2–51), p < 0.001. While OS of REA with 2-CdABR 38% (13–100) versus 74% without (53–100) p 0.7. Conclusion Survival of RO + remains limited. Failure of 1st line in RO + due to DP carries worse prognosis in relation to REA. In DP those who were not salvaged by 2-CdABR, showed dismal outcome. This could not be shown when applied in REA

Patterns of central nervous system complications of post-hematopoietic stem cell transplant in pediatric oncology patients: a single institute experience

Abstract Background Hematopoietic stem cell transplant (HSCT) has been increasingly used in the last few decades, with improved success in offering a cure. CNS complications are an important contributor to morbidity and mortality in HSCT patients. The aim of the study was to evaluate the role of imaging in the detection and assessment of CNSC (central nervous system complications) after HSCT in pediatric oncology patients. The study included consecutive pediatric patients who underwent HSCT for hematologic or solid malignancies at CCHE-57357 (Children Cancer Hospital–Egypt 57357) from January 2011 to March 2019. The age of the patients in the study ranged from 0.9 to 25 years (median age 6.5 years). CT (computed tomography) and/or MRI (magnetic resonance imaging) studies were evaluated for the detection and characterization of CNSC. Results The incidence of post-HSCT CNSC was 13% with a day 100 and 5-year cumulative incidence of 9.3 and 12.5%, respectively. The most commonly observed CNSC detected was disease recurrence, followed by PRES (Posterior reversible encephalopathy syndrome). CNS recurrence of the initial diagnosis, atrophy, and infection were more common at the > 100-day post-HSCT transplant period, while PRES was much more common at < 100-day post-HSCT. Conclusion CNS complications are an important contributor to morbidity and mortality in HSCT patients that require MRI protocols distinctively tailored for each patient, clinical suspicion, and proper imaging assessment for early detection and follow-up